Fulcrum Therapeutics, Inc. (FULC)

9.74 +0.23 (+2.42%) USD  |  NASDAQ  |  Jan 13, 11:48
More

Fulcrum Therapeutics Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for FULC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. --
Biogen, Inc. --
CorMedix, Inc. --
Apellis Pharmaceuticals, Inc. --
NovaBay Pharmaceuticals, Inc. --